Back
Protagonist Therapeutics Vs. Shift4 Payments Industry Stock Comparison
Buy
51
PTGX
Protagonist Therapeutics
Last Price:
45.80
Seasonality Move:
18.58%
Buy
75
FOUR
Shift4 Payments
Last Price:
90.40
Seasonality Move:
29.83%
Buy
51
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $47.62. The Score for PTGX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Shift4 Payments (FOUR)
is a Buy
Is Shift4 Payments a Buy, Sell or Hold?
- The current Shift4 Payments [FOUR] share price is $91.13. The Score for FOUR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- FOUR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $47.62
The current trend is moderately bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
FOUR Stock Price Chart
What is Shift4 Payments's stock price today?
-
The Shift4 Payments share price today is $91.13
The current trend is moderately bearish and FOUR is experiencing slight selling pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.96 | Buy |
| Relative Strength Index (14 RSI): | 60.04 | Buy |
| Chaikin Money Flow: | -140534 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.33 - 47.23) | Buy |
| Bollinger Bands (100): | (35.43 - 45.45) | Buy |
FOUR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.71 | Buy |
| Relative Strength Index (14 RSI): | 51.03 | Buy |
| Chaikin Money Flow: | -11117 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.83 - 94.63) | Sell |
| Bollinger Bands (100): | (69.32 - 88.08) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.18 | Buy |
| 20-day SMA: | 45.98 | Buy |
| 50-day SMA: | 44.76 | Buy |
| 200-day SMA: | 34.2 | Buy |
| 8-day EMA: | 47.35 | Buy |
| 20-day EMA: | 46.42 | Buy |
| 50-day EMA: | 44.35 | Buy |
| 200-day EMA: | 35.57 | Buy |
FOUR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.78 | Sell |
| 20-day SMA: | 92.85 | Sell |
| 50-day SMA: | 86.39 | Buy |
| 200-day SMA: | 74.53 | Buy |
| 8-day EMA: | 92.41 | Sell |
| 20-day EMA: | 91.72 | Sell |
| 50-day EMA: | 86.86 | Buy |
| 200-day EMA: | 75.68 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
Shift4 Payments Earnings Growth & FOUR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.07 per share.
Protagonist Therapeutics Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Shift4 Payments Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||